Navigation Links
Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Date:5/12/2008

rd-looking statements, as defined by the Private Securities Litigation Reform Act of 1995, that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "preliminary"; "potential"; "may"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with the development of MDX-1100, unforeseen safety issues resulting from the administration of antibody products in humans, as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly reports on Form 10-Q. There can be no assurance that such product development efforts will succeed, or whether other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015  Recognizing the unique position Massachusetts ... the most respected organizations in the New England medtech community, ... Industry Council (MassMEDIC), have partnered to celebrate the region,s ... Annual Massachusetts Medtech Week. This celebration will take place May ... Center in Boston . For more information ...
(Date:4/27/2015)... Mass. , April 27, 2015 ... a collaboration with Brainlab AG, a leading software-driven ... planning and surgical navigation. The collaboration provides patients ... Stimulation (DBS) therapy. DBS is intended to treat ... help reduce symptoms for movement disorders such as ...
(Date:4/27/2015)... , April 27, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... the United States Food and Drug Administration ("FDA") verifying ... in place following the warning letter it received from ... letter follows a re-inspection in March 2015 by the ...
Breaking Medicine Technology:First Annual Massachusetts Medtech Week Celebrated this May 2First Annual Massachusetts Medtech Week Celebrated this May 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 2Boston Scientific Announces Strategic Collaboration With Brainlab AG 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 4CryoLife Announces Resolution of FDA Warning Letter 2
... Corporation , today announced that the U.S. Patent and ... which brings their total portfolio to 20 and bolsters ... wireless location systems (RTLS) for hospitals. (Logo: ... cover Awarepoint,s most accurate mesh-based location algorithm to date, ...
... opening ceremony for the world,s largest stem cell medical center ... ( www.rnl.co.kr ), South Korea,s premier adult stem cell firm ... in Beijing, China. Beijing RNL Stem Cell Medical Center is ... Li Hailing, www.yandaco.com ). Beijing RNL Stem Cell Medical ...
Cached Medicine Technology:Awarepoint Advances Industry Leadership with New Patented Technology 2RNL Opens the World's Largest Stem Cell Medical Center in Beijing, China 2
(Date:4/27/2015)... Philadelphia, PA (PRWEB) April 27, 2015 Ticket ... presale tickets in Philadelphia for his upcoming concert on ... The Beatles, will thrill his countless North American fans again ... in conjunction with his "Out There" tour. He will ... will be able to listen to this legendary performer for ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Doctors on ... working on a lien basis for over twenty years. So ... find the best doctor in the Fresno area , ... Dilanchian, DC and his team of medical specialists. With ... a massage therapist, Dilanchian Chiropractic is now helping ...
(Date:4/27/2015)... 2015 Douglas Fitzpatrick not only ... feel secure, but also helps secure homes for animals. On ... will be manning a booth at the 2015 Fetch A ... E. 17th Ave., Columbus, Ohio. , “I am very ... feature hundreds of adoptable pets from more than forty different ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram students (monks) ... raise awareness of the vision of Mount Soma; the ... Ironically, when many of these people moved to the ... were leaving the social and technological world behind. Ashram ... service to a higher cause, deep introspection, and renunciation ...
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices of Dan ... that commitment to a whole new level with the introduction ... for existing and potential clients to contact the law firm. ... value to the firm’s services, #Dan covers Central Florida, South ... offices. , “I knew the pound sign (#) could be ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Mount Soma Monks Do Social Media 2Health News:Dan Newlin Hashtags It With #Dan 2
... study says more than a decade needed to ... -- The number of board-certified emergency doctors in ... hospital emergency department staffing needs in the future, ... scientists suggested that alternative strategies for staffing emergency ...
... announced the expansion of its Sealy office. , ... Sealy, Texas (PRWEB) ... of its Sealy office. Located on Meyer Street the five-year old-practice has ... in many of the surrounding communities as well., , , , ,The ...
... SANTA ANA, Calif., Jan. 9 Grubb & Ellis,Healthcare ... a two-property medical office building portfolio in San Antonio ... The acquisition closed in,December 2008. , ... Antonio, Pecan Valley Medical,Office Building consists of approximately 60,000 ...
... Cells , , NEW YORK, Jan. 9 ... free of signs of juvenile myelomonocytic leukemia (JMML), a ... a transplant with cord blood from the National Cord Blood ... Milstein National Cord Blood Center.Juvenile myelomonocytic leukemia generally affects children ...
... found impairments were mild, but they could signal later ... with diabetes now have to worry about whether their ... that declines in mental function are accelerated among those ... published in the January issue of Neuropsychology , ...
... led by The University of Texas Health Science Center ... train investigators in a ground-breaking area of genetic study ... are trying to discover why some people with known ... The answer may have to do with the interplay ...
Cached Medicine News:Health News:Certified ER Docs in Short Supply to Meet Future Needs 2Health News:Austin County Eye Expands Sealy Eye Clinic Office 2Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 2Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 3Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 4Health News:Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer 2Health News:Diabetes Linked to Cognitive Problems 2Health News:UT leads $2.5 million training program in pioneering area of genetic research 2Health News:UT leads $2.5 million training program in pioneering area of genetic research 3
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
... Hyfrecator has been the #1 product ... electrosurgery for over 60 years. Remote control ... sterile field and decrease procedural time. Dual ... output of the Hyfrecator, the second to ...
Sabre 180, 230V, 50Hz is a powerful niche generator....
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles....
Medicine Products: